Raxatrigine (hydrochloride) – 25 mg

Brand:
Cayman
CAS:
934240-31-0
Storage:
-20
UN-No:
Non-Hazardous - /

Raxatrigine is an inhibitor of voltage-gated sodium channels (Nav; IC50s = 22, 13, 23, 10, 84, 15, 32, and 6 µM for Nav1.1-Nav1.8 channels in a FLIPR membrane potential assay using HEK293 cells).{38414} Its activity is state-dependent at the Nav1.7 channel, with a nine-fold increase in potency for the open/inactivated state (IC50 = 6.3 µM) compared to the closed/resting state (IC50 = 54 µM). Raxatrigine (30 mg/kg, i.p.) decreases spontaneous pain behavior in an OD1 mouse pain model. Formulations containing raxatrigine have been investigated in clinical trials for the treatment of trigeminal neuralgia and lumbosacral radiculopathy (sciatica).  

 

Available on backorder

SKU: 23490 - 25 mg Category:

Description

An inhibitor of voltage-gated sodium channels (IC50s = 22, 13, 23, 10, 84, 15, 32, and 6 µM for Nav1.1- Nav1.8 channels); has state-dependent activity at the Nav1.7 channel (IC50s = 6.3 and 54 µM for open/inactivated and closed/resting states); decreases pain behavior in an OD1 mouse pain model


Formal name: (2S)-5R-[4-[(2-fluorophenyl)methoxy]phenyl]-2-pyrrolidinecarboxamide, monohydrochloride

Synonyms:  GSK1014802A

Molecular weight: 350.8

CAS: 934240-31-0

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Neuroscience|Pain Research